Abstract
AIDS:
Although the advent of protease inhibitors has greatly extended the life expectancy of those living with HIV, they also have introduced the problems of emotionally dealing with a chronic illness. Depression appears to be the most common psychiatric disorder found among HIV-infected individuals. Preliminary evidence suggests that depressive symptoms may be associated with increased mortality. Treatment options are discussed, including psychotherapy and treatment with pharmaceuticals.
MeSH terms
-
Antidepressive Agents / therapeutic use*
-
Combined Modality Therapy
-
Cytochrome P-450 Enzyme System / metabolism
-
Depressive Disorder / complications
-
Depressive Disorder / psychology*
-
Depressive Disorder / therapy
-
Drug Interactions
-
HIV Infections / complications
-
HIV Infections / drug therapy
-
HIV Infections / psychology*
-
HIV Protease Inhibitors / metabolism
-
Humans
-
Psychotherapy*
-
Risk Factors
-
Ritonavir / metabolism
Substances
-
Antidepressive Agents
-
HIV Protease Inhibitors
-
Cytochrome P-450 Enzyme System
-
Ritonavir